NCT05488964

Brief Summary

The aim of this trial is to investigate whether regular endurance exercise during the lactation period will influence breastmilk composition among individuals with overweight/obesity, and secondarily to assess if such changes impact the growth and health of the infants.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
22mo left

Started Sep 2022

Longer than P75 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Sep 2022Mar 2028

First Submitted

Initial submission to the registry

July 6, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 5, 2022

Completed
27 days until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 24, 2025

Completed
2.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2028

Expected
Last Updated

April 8, 2026

Status Verified

April 1, 2026

Enrollment Period

3.2 years

First QC Date

July 6, 2022

Last Update Submit

April 7, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Breastmilk human milk oligosaccharide (HMO) 3'sialyllactose (3'SL)

    Relative concentration of 3'SL in breastmilk

    0 to 8 weeks

Secondary Outcomes (82)

  • Breastmilk human milk oligosaccharide (HMO) 3'sialyllactose (3'SL)

    0 to 4 weeks

  • Breastmilk metabolites

    0 to 8 weeks

  • Breastmilk metabolites

    0 to 4 weeks

  • Breastmilk microRNA

    0 to 8 weeks

  • Breastmilk microRNA

    0 to 4 weeks

  • +77 more secondary outcomes

Other Outcomes (2)

  • Exercise adherence

    0 to 8 weeks

  • Exercise compliance

    0 to 8 weeks

Study Arms (2)

Exercise

EXPERIMENTAL

Regular endurance training for 8 weeks

Behavioral: Exercise

Control

NO INTERVENTION

Habitual living for 8 weeks

Interventions

ExerciseBEHAVIORAL

Supervised endurance training with moderate-to-high intensity 3-4 times weekly.

Exercise

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female
  • Aged 18 years or older
  • Body mass index ≥ 25 kg/m2 pre-pregnancy and/or BMI ≥ 28 kg/m2 postpartum
  • Given birth to a singleton term (after 37 weeks + 0 days) baby
  • Understands oral and written Norwegian

You may not qualify if:

  • On-going pregnancy
  • Known type 1 or type 2 diabetes
  • Known cardiovascular disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept Circulation and Medical Imaging, EXCAR Exercise Lab

Trondheim, Norway

Location

Related Publications (1)

  • Moholdt T, Ashby ER, Tommerdal KH, Lemoine MCC, Holm RL, Saetrom P, Iversen AC, Ravi A, Simpson MR, Giskeodegard GF. Randomised controlled trial of exercise training during lactation on breast milk composition in breastfeeding people with overweight/obesity: a study protocol for the MILKSHAKE trial. BMJ Open Sport Exerc Med. 2023 Oct 6;9(4):e001751. doi: 10.1136/bmjsem-2023-001751. eCollection 2023.

MeSH Terms

Conditions

Obesity

Interventions

Exercise

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Trine Moholdt, PhD

    Norwegian University of Science and Technology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 6, 2022

First Posted

August 5, 2022

Study Start

September 1, 2022

Primary Completion

November 24, 2025

Study Completion (Estimated)

March 1, 2028

Last Updated

April 8, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

All IPD that underlie results in a publication

Shared Documents
STUDY PROTOCOL, ANALYTIC CODE
Time Frame
Starting 6 months after publication
Access Criteria
IPD will be shared upon requests from researchers. The principal investigator (Trine Moholdt) will review requests.

Locations